Using LMP1 knockout virus infection in a humanized mouse model, it has been clearly shown that activated T cells can substitute for the requirement of LMP1 expression in EBV-induced B-cell lymphomas by providing a source of CD40 signaling. Here, PDLIM7 is linked to B-cell non-Hodgkin lymphoma.